The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 29, 2013
Filed:
Nov. 15, 2010
Esther Martinborough, San Diego, CA (US);
Marcus F. Boehm, San Diego, CA (US);
Adam Richard Yeager, San Diego, CA (US);
Junko Tamiya, Carlsbad, CA (US);
Liming Huang, San Diego, CA (US);
Enugurthi Brahmachary, San Diego, CA (US);
Manisha Moorjani, San Diego, CA (US);
Gregg Alan Timony, Cardiff by the Sea, CA (US);
Jennifer L. Brooks, Encinitas, CA (US);
Robert Peach, San Diego, CA (US);
Fiona Lorraine Scott, San Diego, CA (US);
Michael Allen Hanson, San Marcos, CA (US);
Esther Martinborough, San Diego, CA (US);
Marcus F. Boehm, San Diego, CA (US);
Adam Richard Yeager, San Diego, CA (US);
Junko Tamiya, Carlsbad, CA (US);
Liming Huang, San Diego, CA (US);
Enugurthi Brahmachary, San Diego, CA (US);
Manisha Moorjani, San Diego, CA (US);
Gregg Alan Timony, Cardiff by the Sea, CA (US);
Jennifer L. Brooks, Encinitas, CA (US);
Robert Peach, San Diego, CA (US);
Fiona Lorraine Scott, San Diego, CA (US);
Michael Allen Hanson, San Marcos, CA (US);
Receptos, Inc., San Diego, CA (US);
Abstract
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile